DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Agarwal N, Chowdhury S, Bjartell A. et al.
Time to second progression (PFS2) in patients (pts) from TITAN with metastatic castration-sensitive prostate cancer (mCSPC) by first subsequent therapy (hormonal vs. taxane).
J Clin Oncol 2020;
38 (Suppl. 06) 82
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.